BACKGROUND Miliary tuberculosis occurs as a result of hematogenous dissemination of Mycobacerium tuberculosis. This can occur due to progressive primary infection, reactivation of latent focus with subsequent spread, or rarely via iatrogenic origin. CASE PRESENTATION This is a case of 21 year-old woman presented with hydronephrosis and hematuria due to unrecognized renal tuberculosis. She und...

Background: Tuberculosis remains a public health problem worldwide, and tuberculosis in pregnancy in particular can have effects on both mother and infant. Findings: We report a case of a 22year-old female presenting in preterm labor at 32 weeks gestation. Her pregnancy had been complicated by hearing loss and weight loss, and at the time of delivery, she was diagnosed with tuberculous otitis m...

Tuberculosis continues to be a leading cause of morbidity and mortality in the 21st century. The rise of multiresistant strains of Mycobacterium tuberculosis associated with an increase of disseminated tuberculosis due to the higher numbers of Human Immunodeficiency Virus (HIV) infected patients is threatening to compromise tuberculosis control worldwide. Here we report a rare case of dissemina...

Because tuberculosis of the skull is relatively unusual occurrence, it may not be immediately recognized. It responds readily to chemotherapy and should be suspected in disseminated tuberculosis or in any draining lesion of the skull that is sterile or fails to respond to conventional antibiotic therapy.

The presented observation describes an example of effective treatment the patient with disseminated destructive pulmonary tuberculosis preXDR. included staged surgery using original method anterior mediastinum plasty a mesh implant. resulted in following outcomes: stabilization tuberculous disease, persistent sputum conversion, minimization overdistension only lung, absence mediastinal hernia a...

Tuberculosis (TB) is a communicable disease caused by the bacillus Mycobacterium tuberculosis and leading cause of death single infectious agent overall. According to WHO Global TB Report, India contributes 26% global burden TB. Currently, four-drug regimen comprising Rifampicin, Isoniazid, Pyrazinamide, Ethambutol approved for treatment drug-sensitive The management cutaneous adverse drug reac...

Tumor necrosis factor-α inhibitors are now considered as standard therapy for patients with severe inflammatory bowel disease who do not respond to corticosteroids, but they carry a definite risk of reactivation of tuberculosis. We present a case in which a patient with inflammatory bowel disease developed a de novo tuberculosis infection after the start of anti-tumor necrosis factor-α treatmen...